US 10500290
Peptide reagents and methods for detection and targeting of dysplasia, early cancer and cancer
granted A61KA61K38/00A61K45/06
Quick answer
US patent 10500290 (Peptide reagents and methods for detection and targeting of dysplasia, early cancer and cancer) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/00, A61K45/06, A61K49/0032, A61K49/0043